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Bovine papillomavirus (BPV) is an oncogenic virus related to serious livestock diseases. Oncoproteins encoded by BPV are involved
in several steps of cellular transformation and have been reported as presenting clastogenic effects in peripheral lymphocytes and
primary culture cells. The aim of this study was to evaluate the clastogenic potential of BPV types 1, 2, and 4 by comet assay.
Peripheral blood was collected from 37 bovines, 32 infected with different levels of papillomatosis (12 animals have no affection)
and five calves, virus free (negative control).The viral identification showed presence of more than one virus type in 59.375% of the
infected animals. Comet assay was performed according to alkaline technique.The Kruskal-Wallis test showed statistical difference
between the negative control group and infected animals (𝑃 = 0.0015). The Dunn post hoc test showed difference comparing the
infected animals with calves. Mann-Whitney U test verified no difference between animals infected with only one viral type and
animals presenting more than one viral type. The comet assay is considered an efficient tool for assessment of damage in the host
chromatin due to viral action, specifically highlighting viral activity in blood cells.
1. Introduction
Bovine papillomavirus (BPV) is a widespread oncogenic
virus found worldwide belonging to the Papillomaviridae
family, which displays tropism for squamous epithelial and
mucosal tissues. These viruses are associated with benign
and malignant epithelial lesions. Specifically, BPV presents
a double-stranded circular DNA, not coiled, with approxi-
mately 8 kb, surrounded by an icosahedral capsid consisting
of 360 copies of the L1 protein of 55 kDa, 72 capsomeres
arranged in approximately 12 copies of the L2 protein, 39 kDa
[1–8]. The papillomavirus genome is divided into three
regions: early, late, and noncoding long control region (LCR),
separated by two polyadenylation sites [3]. The early control
region occupies 50% of the viral genome and encodes E1,
E2, E3, E4, E5, E6, and E7 proteins. The late control region
occupies 40% of the genome and contains the genes that
codify L1 and L2 capsid proteins and LCR, which comprises
10% of the genome, with 850 bp. However, it also contains
the origin of replication and the binding sites of multiple
transcription factors [3]. Oncoproteins encoded by BPV are
involved in several steps of the cell transformation [1, 9].
In cattle, the correlation between papillomavirus and
cancer has been investigated in view of the economic costs
generated by viral infection [1, 8, 10, 11]. BPV is the etiological
agent of bovine papillomatosis, infectious disease, charac-
terized by the presence of hyperproliferative skin lesions
(papillomas), causing significant economic loss to livestock
ranchers and can progress to cancer with the action of
cofactors [8, 10, 12].
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Currently, there are 13 BPV virus types described in the
literature, although this number may be greater than twenty
[7, 9]. The virus types are divided into three genres: Delta-
papillomavirus (BPV-1, -2, and -13), Epsilonpapillomavirus
(BPV-5 and -8), and Xipapillomavirus (BPV-3, -4, -6, -8, -9,
-10, and -12), as well as the BPV-7 that remains not ranked in
any genre [7]. Beside these, there are 16 new putative BPVs
(BAA-1 to -4, BAPV-2 to -5, BAPV-7 to -10, BAPPV11MY
and BPV/BR-UEL-2 to -5) [13]. According to Zhu et al. [13],
BAA1 was detected in tongue epithelial papilloma, being
designated BPV-12, and BPV/BR-UEL-4 described in ear
cutaneous lesions was designated BPV-13 [9].
According to Stocco dos Santos et al. [1], papillomavirus
can act on host chromatin causing cytogenetic alterations,
such as changes in ploidy, chromatin gaps and breaks,
dicentric chromosomes and rings. Significant increase of
chromosomal aberrations was detected in animals infected
with BPV, affecting genomic stability [4]. However, to date,
there are no studies evaluating the BPV clastogenic potential
in peripheral blood cells analyzed by comet assay.
Comet assay or single cell gel electrophoresis was intro-
duced by O¨stling and Johanson [14] and later modified by
Singh et al. [15]. The comet assay is a simple and versatile
technique that requires few eukaryotic cells, as well as having
a vast DNA damage spectrum detection capacity [16–19]. In
the test, cells are engulfed by agarose gel and spread over the
slide, and then subjected to an electric field that promotes free
DNA fragment migration, with the appearance of a comet
[15]. The nuclear region causes the head of the comet to
fragment, and the length of the tail is directly related to the
intensity of the damage.
The objective of this work was to evaluate the clastogenic
potential of BPV types 1, 2, and 4 through comet assay in
infected animals presenting cutaneous papillomatosis symp-
toms (hyperproliferative lesions-papillomas), asymptomatic
(without papillomas) and calves, not infected, as negative
control. The efficacy of the comet assay in clastogenic eval-
uations justifies this study.
2. Material and Methods
2.1. Ethics Statements. The protocols used in this study was
approved by the Ethical Committee in Research of the Uni-
versidade Federal de Sa˜o Paulo (Protocol number 1829/09)
assigned by the President of this committee. All efforts were
made to minimize any suffering in the animals.
2.2. BPV Diagnosis
2.2.1. Animal Selection. 37 bovines (Bost aurus) were selected:
32 adults, 12 asymptomatic (without visible cutaneous papil-
lomas) and 20 symptomatic (with visible cutaneous papillo-
mas) and 5 newborn calves that were separated from their
mother after birth and did not receive breast milk. The
presence of papillomas in others organs was not evaluated
due the absence of clinical characteristics that suggest bladder
and/or esophageal cancer. The farm does not have the pres-
ence of bracken fern Pteridium aquilinum that is involved in
oncogenic and mutagenic processes in function of quercetin
presence [20]. These calves were isolated in order to obtain
virus negative controls. Blood sample. The peripheral blood
samples were collected using the EDTA vacutainer. Blood
DNA extraction. The extraction of DNA from peripheral
blood cells was performed using the GenomicPrep Blood
Mini Kit Illustra Spin (GE Healthcare, Buckinghamshire,
UK), which uses enzymatic digestion method with protease
K, according to the manufacturer. The quality of obtained
DNAwas verified using PCR by amplifying a bovine 𝛽-globin
gene fragment [21].
2.2.2. Viral Identification. Viral identification was performed
using specific primers for BPV-1 (forward: 5󸀠-GGAGCG-
CCTGCTAACTATAGGA-3󸀠 and reverse: 5󸀠-ATCTGT-
TGTTTGGGTGGTGAC-3󸀠), which amplifies the L1 gene,
resulting in a 301 bp amplicon, BPV-2 (forward: 5󸀠-GTT-
ATACCACCCAAAGAAGACCCT-3󸀠 and reverse: 5󸀠-CTG-
GTTGCAAC¸AGCTCTCTTTCTC-3󸀠), which amplifies the
L2 gene, resulting in a 164 amplicon, and BPV-4 (forward;
5󸀠-GCTGACCTTCCAGTCTTAAT-3󸀠 and reverse; 5󸀠-CAG-
TTTCAATCTCCTCTTCA-3󸀠), which amplifies the E7 gene,
resulting in a 170 bp amplicon. We choose these primers
because the virus types are often observed in Brazil and
in function of the association with esophageal (BPV-4) and
bladder cancer (BPV-1 and -2). In detail, the amplification
reactions were performed in a Veriti 96-well thermal cycler
(Applied Biosystems, Singapore), withMasterMix (Promega,
Madison, USA), under the following conditions: 5 minutes
at 95∘C, followed by 35 cycles of 1 minute and 30 seconds
at 98∘C, 2 minutes at 52∘C, and 1 minute and 30 seconds at
72∘C and a final extension step of 5 minutes at 72∘C, for 𝛽-
globin and specific primers.The PCR products were analyzed
in 2% agarose gel electrophoresis stained with GelRed in
TAE buffer, visualized under UV light. The images were
captured through the software Kodak 1D 3.6.5. Cloned BPV-
1, -2 and -4 genomes in Escherichia coli D5H𝛼 were used as
positive controls. These clones form part of the biological
collection of Genetic Laboratory of Butantan Institute. The
fragments were purified using Illustra GFX PCR DNA and
Gel Band Purification Kit (GE Healthcare, Buckinghamshire,
UK). DNA concentration and purity were determined in a
spectrophotometer BioPhotometer plus (Eppendorf, Ham-
burg, Germany) and submitted to sequencing reactions.
Sequencing. The purified amplified products were sequenced
in an ABI377 PRISM Genetic Analyzer. The quality of DNA
sequences was checked, the overlapping fragments were
assembled using the BioEdit package software BioEdit pack-
age 7.0.9.0 [22], and the nucleotide sequences were compared
through BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
2.3. Comet Assay. Comet assay was performed according
to alkaline technique [15]. An aliquot of 10 𝜇L (0.1 ×
105 cells) was transferred to 0.2mL polypropylene tubes
and mixed with 75𝜇L of low-melting-point agarose (0.7%
in PBS) at 37∘C, LMA optimum concentration (≤0.8%),
without affecting the DNA migration [17], which was
spread onto 76 × 26mm microscope slides precoated with
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normal-melting-point agarose (1.5% in PBS) at 60∘C and
dried at 22∘C overnight. After the agarose had solidified
(4∘C for 10min), the coverslips were carefully removed, and
the slides were immersed in lysis solution (2.5M NaCl,
100mM Na
2
EDTA, 10mM Tris-HCl; pH 10; 1% Triton X-
100, and 10% DMSO) for 1 hour at 4∘C and then placed
into a horizontal electrophoresis apparatus filled with buffer
(1mM Na
2
EDTA, 300mM NaOH) at 4∘C. The slides were
incubated for 40min in this buffer to unwind the DNA. The
electrophoresis was run for 20min at fixed voltage of 25V
(0.83V/cm) and 300mA. At the end of electrophoresis, the
slides were washed three times with neutralization buffer
(0.4M Tris-HCl, pH 7.5) and once in 100% ethanol. All
steps described above were carried out with the lights out
to avoid DNA damage. The slides were stained with 20𝜇L of
propidium iodide (4𝜇g/mL) and visualized inCarl ZeissAxio
Scope A1 fluorescent microscopy. Nucleoids were classified
from 0 (without lesion) to 2 (major damage), and the number
of nucleoids observed per class was multiplied to the class
value, resulting in a comet score. Statistical analysis. The
data were analyzed using the Kruskal-Wallis test, followed
by post hoc Dunn test and Mann-Whitney U test, both with
significance level of 5%, through BioEstat 5.3. software.
3. Results
3.1. Viral Genotyping. PCR using specific primers to 𝛽-globin
revealed DNA quality enough for further PCR procedures:
all samples resulted in a 450 bp amplicon. We selected the
specific primers for BPV-1, -2, and -4 due to their prevalence
in the herd, and we could detect the virus sequences in
peripheral blood cells collected from the adult animals,
with and without skin papillomas (Figure 1(a)). The resulting
bandswere purified and sequenced to confirm the genotyping
of the amplification products. The sequences were aligned
through the BioEdit 7.0.9.0, and the nucleotide comparison
was done through the BLAST tool, confirming the specificity
of the primers employed. Using these primers, coinfection
was reported in 59.375% of the infected bovines—19 animals
(Table 1(a)). The use of these primers did not detect the
presence of BPV in calf peripheral blood samples, with this
group being considered a negative control.
3.2. Comet Assay. The samples of peripheral blood cells
collected from infected animals and calves (negative control)
were evaluated through comet assay, counting 100 nucleoids
per sample that were evaluated and classified as 0 (without
damage), 1 (medium damage), and 2 (maximum damage)
according to Figure 2. The nucleoid value per class was
multiplied by the respective class value, resulting in the comet
score (Table 1(a)).
Based on these data, a Kruskal-Wallis test was used,
with 5% significance level, through BioEstat 5.3. software
to compare the different groups (infected and not infected
group). The test reveled statistical differences between the
groups (𝐻 = 12.9714 and 𝑃 value = 0.0015). The Dunn
post hoc test showed difference in score values among
calf and infected animals (asymptomatic and symptomatic)
(a)
(b)
(c)
(d)
Figure 1: Electrophoresis’s images of: (a) (𝛽-globin amplification,
resulting in an amplicon of 450 bp), (b) (amplification of L1 gene,
using primer to BPV-1, showing an amplicon of 301 bp), (c) (ampli-
fication of L2 gene, using primer to BPV-2, showing an amplicon
of 164 bp) and (d) (amplification of E7 gene, using primer to BPV-4,
showing an amplicon of 170 bp), being C− (negative control) and C+
(positive control).
(Table 1(b)). Mann-Whitney U test was done using the same
software to compare the level of clastogenicity between
animals, which showed just one virus type, and coinfected
cattle.The results did not reveal statistical differences between
animals infected with only one viral type and animals
presenting more than one viral type (Table 1(c)).
4. Discussion
The carcinogenicmechanisms related to BPV are not yet fully
elucidated; however, it is known that themalignancy is caused
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Table 1: (a) Results of molecular diagnosis of calves (negative control) and asymptomatic and symptomatic adult cattle, showing the BPV
type, the frequency of nucleoids observed per class, and the comet score. (b) Kruskal-Wallis statistic to compare the clastogenicity among
calves, asymptomatic and symptomatic cattle, from the comet score. (c) Comparison between comet score observed in monoinfected and
coinfected bovines through Mann-Whitney U test.
(a)
Controls Clinical Virus type Class of nucleoids Score
0 1 2
1 Asymptomatic — 93 4 3 10
2 Asymptomatic — 92 5 3 11
3 Asymptomatic — 96 1 3 7
4 Asymptomatic — 90 8 2 12
5 Asymptomatic — 95 3 2 7
Infected bovines
6 Asymptomatic BPV-1 15 60 25 110
7 Asymptomatic BPV-2 57 36 7 50
8 Asymptomatic BPV-1 75 19 6 31
9 Asymptomatic BPV-1, -2 43 17 40 97
10 Asymptomatic BPV-1 73 19 8 35
11 Asymptomatic BPV-1, -2 47 26 27 80
12 Asymptomatic BPV-1 38 26 36 98
13 Asymptomatic BPV-1, -2 62 13 25 63
14 Asymptomatic BPV-2 72 21 7 35
15 Asymptomatic BPV-1, -2 63 12 25 62
16 Asymptomatic BPV-1, -2 58 8 34 76
17 Asymptomatic BPV-1, -2 40 42 18 78
18 Symptomatic BPV-1, -2 61 30 9 48
19 Symptomatic BPV-2 22 13 65 143
20 Symptomatic BPV-1, -2 65 12 23 58
21 Symptomatic BPV-1, -2 57 21 22 65
22 Symptomatic BPV-1, -2, -4 31 31 38 107
23 Symptomatic BPV-1 89 6 5 16
24 Symptomatic BPV-1 92 2 6 14
25 Symptomatic BPV-1 69 25 6 37
26 Symptomatic BPV-1 41 10 49 108
27 Symptomatic BPV-1, -2, -4 70 21 9 39
28 Symptomatic BPV-1, -2, -4 65 26 9 44
29 Symptomatic BPV-2 87 8 5 18
30 Symptomatic BPV-1, -2 0 66 34 134
31 Symptomatic BPV-1, -2 60 31 9 49
32 Symptomatic BPV-2 52 23 25 73
33 Symptomatic BPV-1, -2 72 9 19 47
34 Symptomatic BPV-1, -2 91 7 2 11
35 Symptomatic BPV-1, -2 74 15 11 37
36 Symptomatic BPV1, -2, -4 82 13 5 23
37 Symptomatic BPV-1, -2 36 22 42 106
(b)
Groups Average post Z calculated P value
Calves and asymptomatic 3.300 3.5348 <0.05
Calves and symptomatic 23.666 3.1097 <0.05
Asymptomatic and symptomatic 20.125 0.8961 n.s.
𝐻 = 12.9714, 𝑃 = 0.0015, 𝑅 of calves = 16.5, 𝑅 of asymptomatic = 284.0 and 𝑅 of symptomatic = 402.5.
BioMed Research International 5
(c)
Monoinfected sample Score Coinfected sample Score
6 110 9 97
7 50 11 80
8 31 13 63
10 35 15 62
12 98 16 76
14 35 17 78
19 143 18 48
23 16 20 20
24 14 21 21
25 37 22 22
26 108 27 39
29 18 28 44
32 74 30 134
— — 31 49
— — 33 47
— — 34 11
— — 35 37
— — 36 23
— — 37 106
Mann-Whitney U test results:𝑈 = 102.5, 𝑍(𝑈) = 0.80, P value = 0.21.
(a) (b)
Figure 2: (a) Images of class 0 nucleoids, observed in calves (negative control) and (b) class 2 nucleoids, observed in symptomatic adult
bovine, showing DNA fragmentation that is indicative of clastogenicity.
by mutations induced by the virus, associated with the action
of viral protein E6, which accelerates the degradation of p53
and E7, which degrades the tumor suppressor protein pRb.
These processes change the transcriptional pathway through
degradation of transcription factors, activating telomerase,
affecting the DNA repair system, and leading to an increase
of damage in host genetic material [6, 23–25]. According
to You [6], the protein E7 interacts with microtubules in
mitosis, causing defects in the alignment of chromosomes
during pre-metaphase, resulting in cytogenetic alteration [1,
26]. Wade et al. [25] discussed that the BPV oncoproteins
can act on the signal transduction, allowing the return
of interphase spinous epithelial cells to synthesis phase,
resulting in mutated cell proliferation. Oncoproteins E6
and E7 induce immortalization of transformed cells [3].
According to Primrose and Twyman [27], these oncoproteins
are required in the process of viral replication and act in
the process of oncogenic transformation of the host cell.
Furthermore, the accelerated p53 proteasomal degradation
has a prominent role in the carcinogenic action of the virus,
since the p53 protein function is to check the integrity of the
genome, preventing the proliferation of mutated cells. The
p53 accumulates in the cell nucleus, keeping the mitotic cycle
in early G1 phase by activating p21 gene, whose gene product
inhibits the action of cycling-dependent kinases (CDKs) and
activates genes related to repair system [28].
Melo et al. [26] analyzed peripheral blood lymphocytes
obtained from clinically asymptomatic bovines and showed
a high level of chromosomal aberrations, suggesting the BPV
action in the host chromatin even before the clinical manifes-
tation of papillomatosis.These data also indicate that the skin
lesions (papillomas) represent visible clinical manifestations,
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but the virus or its DNA sequences, detected in peripheral
blood, can represent a potential risk to carcinogenesis.
In this study, we verified BPV clastogenic action by comet
assay indicating chromatin instability.The comet assay results
demonstrated that the BPV is able to induce severe DNA
damages, which hinder the repair system, this is because
the assay allows to evaluate the DNA double-strand breaks
(DSBs) and critical lesions that are involved in genomic
instability [29–31].
The DSB is associated with the homologous recombina-
tion from the formation of DNA simple strand that invades
the template strand, originating a Holliday junction, which
migrates to the resolution of heteroduplex [29, 31]. However,
unrepaired DSBs leave to apoptosis or cell-cycle arrest,
resulting in carcinogenesis [29]. There are lines of evidence
that unrepaired DSBs could leave to telomeric breaks and
fusion events, also associated with oncogenic process [29, 31].
The viral oncoproteins affect the repair system, allowing
an accumulation of stochastic mutations and resulting in
increased genomic instability [17]. According to Duensing
and Mu¨nger [23], breaks in DNA affect the cell-cycle check-
point that is associated with genomic instability, leading to
hyper proliferation, featuring an oncogenic process. Accord-
ing to the European Study Group on Health’s Biomarkers,
cytogenetic findings, as a high frequency of chromosomal
aberrations, including breaks in single or double-stranded,
are associated to the carcinogenesis [32]. So, at the same time
the presence of BPV is causing DSBs, the virus affects the
repair system, favoring oncogenic process associated with
unrepaired DSBs.
The virus presence in the blood can suggest one alter-
native pathway to infection, in which asymptomatic but
infected cattle could turn symptomatic from a tissue injury,
considering that a lesion causes an inflammatory processwith
lymphocyte infiltration [33]. The presence of BPV in leuko-
cyteswas demonstrated, had been observed theBPVpresence
in peripheral blood mononuclear cells [33] and the presence
of L1 protein in CD4+ and CD8+ leukocytes, representing
a potential infection sites to BPV-2 [34]. The possibility of
the existence of endogenous pathway of infection has been
discussed by Wobeser et al. [33], who suggested that the
mononuclear cells act as a source of infection for inflam-
mation sites, as inflamed areas become more susceptible to
infection by BPV. Furthermore, it is known that lymphocytes
express heparan sulfate, being cells susceptible to infection by
papillomavirus [33]. Another observation that supports the
possibility of infection was reported by Hartl et al. [35], who
found that the spontaneous regression of papillomavirus in
transient infections in humans and cattle is accompanied by
an accumulation of active lymphocytes CD4+ and CD8+. So,
in this pathway, the infiltration of BPV infected cell could
develop a tumorigenic process from a clonal evolution started
in a histologically normal tissue [35, 36].
5. Conclusion
This study presents direct evidence of DNA damage related
to bovine papillomavirus in blood cells, indicating a viral
activity in peripheral blood. The levels of damage were
analyzed in order to verify if the presence of more than
one viral type could increase the clastogenic viral action,
but no significant differences could be detected. The results
showed the same DNA damage both in presence or absence
of cutaneous papillomas, indicating that the presence of
bovine papillomatosis just represents clinical symptoms due
the BPV presence; however, the BPV presence in peripheral
blood leaves to double-stranded breaks, which is associated
to carcinogenesis, affecting the healthy animal, as previously
reported [1, 26]. Comet assay can be discussed as an inter-
esting technique to evaluate DNA damage which, in this
special situation, is related to viral action, demonstrating viral
activity in different sites as blood cells.
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